Since the action of natural compounds frequently reveals distinctive and novel mechanisms in anticancer research, it is offering to investigate the specific biological events related to GPX4 degradation in NSCLC cells following treatment with natural TFEB activators. Here, GPX4 is linked to non-small cell lung carcinoma.